Literature DB >> 24261358

Contrast-enhanced CT quantification of the hepatic fractional extracellular space: correlation with diffuse liver disease severity.

Maurice H Zissen1, Zhen Jane Wang, Judy Yee, Rizwan Aslam, Alexander Monto, Benjamin M Yeh.   

Abstract

OBJECTIVE: The purpose of this study was to determine whether contrast-enhanced CT quantification of the hepatic fractional extracellular space (ECS) correlates with the severity of diffuse liver disease.
MATERIALS AND METHODS: The cases of 70 patients without (46 men, 24 women; mean age, 59.1 years) and 36 patients with (23 men, 13 women; mean age, 63.1 years) cirrhosis who had undergone unenhanced and 10-minute delayed phase contrast-enhanced CT were retrospectively identified. By consensus one experienced radiologist and one trainee measured the CT attenuation of the liver and aorta to estimate the fractional ECS, defined as the ratio of the difference between the attenuation of the liver on 10-minute and unenhanced images to the difference between the attenuation of the aorta on 10-minute and unenhanced images multiplied by 1 minus the hematocrit. Findings were correlated with each patient's Model of End-Stage Liver Disease (MELD) score.
RESULTS: The mean MELD score was higher in patients with than in those without cirrhosis (14.3 ± 7.3 versus 7.20 ± 2.4, p < 0.0001). The mean fractional ECS was significantly greater in patients with cirrhosis than in those without cirrhosis (41.0% ± 9.0% versus 23.8% ± 6.3%, p < 0.0001). The fractional ECS correlated with the MELD score (r = 0.572, p < 0.0001) and was predictive of cirrhosis with an area under the receiver operating characteristic curve of 0.953 (p < 0.0001). The sensitivity and specificity of an expanded fractional ECS greater than 30% for the prediction of cirrhosis were 92% and 83%. Multivariate linear regression revealed that the fractional ECS is complementary to the MELD score as a predictor of cirrhosis (p < 0.0001).
CONCLUSION: Noninvasive contrast-enhanced CT quantification of the fractional ECS correlates with the MELD score, an indicator of the severity of liver disease, and merits further study.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24261358      PMCID: PMC5317270          DOI: 10.2214/AJR.12.10039

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  33 in total

1.  Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging.

Authors:  Diego A Aguirre; Cynthia A Behling; Elliot Alpert; Tarek I Hassanein; Claude B Sirlin
Journal:  Radiology       Date:  2006-05       Impact factor: 11.105

2.  Cirrhotic liver enhancement on dual-phase helical CT: comparison with noncirrhotic livers in 146 patients.

Authors:  O Vignaux; P Legmann; J Coste; C Hoeffel; A Bonnin
Journal:  AJR Am J Roentgenol       Date:  1999-11       Impact factor: 3.959

Review 3.  Cirrhosis: CT and MR imaging evaluation.

Authors:  Giuseppe Brancatelli; Michael P Federle; Roberta Ambrosini; Roberto Lagalla; Alessandro Carriero; Massimo Midiri; Valérie Vilgrain
Journal:  Eur J Radiol       Date:  2006-12-04       Impact factor: 3.528

4.  Assessment of the severity of liver disease and fibrotic change: the usefulness of hepatic CT perfusion imaging.

Authors:  Kazuhiko Hashimoto; Takamichi Murakami; Keizo Dono; Masatoshi Hori; Tonsok Kim; Masayuki Kudo; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Hiroaki Nagano; Koji Umeshita; Hironobu Nakamura; Morito Monden
Journal:  Oncol Rep       Date:  2006-10       Impact factor: 3.906

5.  Cholangiocarcinoma: delayed CT contrast enhancement patterns.

Authors:  J M Lacomis; R L Baron; J H Oliver; M A Nalesnik; M P Federle
Journal:  Radiology       Date:  1997-04       Impact factor: 11.105

6.  Frequently asked questions: iodinated contrast agents.

Authors:  Michael A Bettmann
Journal:  Radiographics       Date:  2004-10       Impact factor: 5.333

7.  Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin.

Authors:  Thierry Poynard; John McHutchison; Michael Manns; Rob P Myers; Janice Albrecht
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

8.  Distinguishing adrenal adenomas from nonadenomas: combined use of diagnostic parameters of unenhanced and short 5-minute dynamic enhanced CT protocol.

Authors:  Takuro Kamiyama; Yoshihiko Fukukura; Tomohide Yoneyama; Koji Takumi; Masayuki Nakajo
Journal:  Radiology       Date:  2008-11-26       Impact factor: 11.105

9.  Delayed enhancement of fibrotic areas in hepatic masses: CT-pathologic correlation.

Authors:  J Yoshikawa; O Matsui; M Kadoya; T Gabata; K Arai; T Takashima
Journal:  J Comput Assist Tomogr       Date:  1992 Mar-Apr       Impact factor: 1.826

10.  A meta-analysis of transient elastography for the detection of hepatic fibrosis.

Authors:  Justin Stebbing; Lavanta Farouk; George Panos; Mike Anderson; Long R Jiao; Sundhiya Mandalia; Mark Bower; Brian Gazzard; Mark Nelson
Journal:  J Clin Gastroenterol       Date:  2010-03       Impact factor: 3.062

View more
  21 in total

1.  Dual-energy CT quantification of fractional extracellular space in cirrhotic patients: comparison between early and delayed equilibrium phases and correlation with oesophageal varices.

Authors:  Giuseppe Cicero; Silvio Mazziotti; Salvatore Silipigni; Alfredo Blandino; Vito Cantisani; Stefano Pergolizzi; Tommaso D'Angelo; Alberto Stagno; Sergio Maimone; Giovanni Squadrito; Giorgio Ascenti
Journal:  Radiol Med       Date:  2021-03-14       Impact factor: 3.469

2.  Quantitative detection of cirrhosis: towards the development of computer-assisted detection method.

Authors:  Hannu T Huhdanpaa; Peng Zhang; Venkataramu N Krishnamurthy; Chris Douville; Binu Enchakolody; Chris Chou; Sampathkumar Ethiraj; Stewart Wang; Grace L Su
Journal:  J Digit Imaging       Date:  2014-10       Impact factor: 4.056

Review 3.  Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel.

Authors:  Jeanne M Horowitz; Sudhakar K Venkatesh; Richard L Ehman; Kartik Jhaveri; Patrick Kamath; Michael A Ohliger; Anthony E Samir; Alvin C Silva; Bachir Taouli; Michael S Torbenson; Michael L Wells; Benjamin Yeh; Frank H Miller
Journal:  Abdom Radiol (NY)       Date:  2017-08

4.  Extracellular volume fraction determined by equilibrium contrast-enhanced multidetector computed tomography as a prognostic factor in unresectable pancreatic adenocarcinoma treated with chemotherapy.

Authors:  Yoshihiko Fukukura; Yuichi Kumagae; Ryutaro Higashi; Hiroto Hakamada; Koji Takumi; Kosei Maemura; Michiyo Higashi; Kiyohisa Kamimura; Masanori Nakajo; Takashi Yoshiura
Journal:  Eur Radiol       Date:  2018-06-19       Impact factor: 5.315

Review 5.  Imaging of Hepatic Fibrosis.

Authors:  Rishi Philip Mathew; Sudhakar Kundapur Venkatesh
Journal:  Curr Gastroenterol Rep       Date:  2018-08-29

6.  Extracellular volume fraction determined by equilibrium contrast-enhanced dual-energy CT as a prognostic factor in patients with stage IV pancreatic ductal adenocarcinoma.

Authors:  Yoshihiko Fukukura; Yuichi Kumagae; Ryutaro Higashi; Hiroto Hakamada; Masatoyo Nakajo; Kosei Maemura; Shiho Arima; Takashi Yoshiura
Journal:  Eur Radiol       Date:  2019-11-14       Impact factor: 5.315

Review 7.  Non-invasive diagnosis of advanced fibrosis and cirrhosis.

Authors:  Suraj Sharma; Korosh Khalili; Geoffrey Christopher Nguyen
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

8.  Comparison of hepatocellular carcinoma conspicuity on hepatobiliary phase images with gadoxetate disodium vs. delayed phase images with extracellular cellular contrast agent.

Authors:  So Yeon Kim; En-Haw Wu; Seong Ho Park; Z Jane Wang; Thomas A Hope; Judy Yee; Li-Qin Zhao; Wei-Chou Chang; Benjamin M Yeh
Journal:  Abdom Radiol (NY)       Date:  2016-08

Review 9.  Elastography in Chronic Liver Disease: Modalities, Techniques, Limitations, and Future Directions.

Authors:  Aparna Srinivasa Babu; Michael L Wells; Oleg M Teytelboym; Justin E Mackey; Frank H Miller; Benjamin M Yeh; Richard L Ehman; Sudhakar K Venkatesh
Journal:  Radiographics       Date:  2016-09-30       Impact factor: 5.333

10.  Dual-source dual-energy CT in the evaluation of hepatic fractional extracellular space in cirrhosis.

Authors:  Antonio Bottari; Salvatore Silipigni; Maria Ludovica Carerj; Antonino Cattafi; Sergio Maimone; Maria Adele Marino; Silvio Mazziotti; Alessia Pitrone; Giovanni Squadrito; Giorgio Ascenti
Journal:  Radiol Med       Date:  2019-10-05       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.